Usability Validation of Patient Monitoring Device for Pressure Injury Prevention and Fall Detection
Launched by MASIMO CORPORATION · Apr 14, 2017
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. At least 18 years of age
- • 2. ICU patient
- • 3. Primarily bedbound subjects
- • 4. Able to be monitored for a minimum of approximately 8 hours
- Exclusion Criteria:
- • 1. Pregnancy
- • 2. Prisoner status
- • 3. Pressure injury stage 2, 3, or ungroupable
- • 4. Has a pacemaker or internal defibrillator
- • 5. Has a history of complications with a similar study
- • 6. Has any medical condition which in the judgment of the Investigator, renders them inappropriate for participation in this study
About Masimo Corporation
Masimo Corporation is a global leader in innovative non-invasive monitoring technologies, dedicated to improving patient outcomes and safety in healthcare settings. Renowned for its groundbreaking advancements in pulse oximetry and non-invasive monitoring solutions, Masimo’s products are utilized in hospitals, clinics, and homecare environments worldwide. The company actively engages in clinical trials to validate the efficacy and safety of its technologies, contributing to evidence-based practices that enhance patient care. With a commitment to research and development, Masimo strives to advance medical technology and support clinicians in delivering high-quality healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials